Tactile Systems Technology Inc
$ 25.73
2.39%
17 Apr - close price
- Market Cap 571,718,000 USD
- Current Price $ 25.73
- High / Low $ 25.94 / 25.27
- Stock P/E 30.65
- Book Value 9.76
- EPS 0.82
- Next Earning Report 2026-05-04
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.06 %
- ROE 0.09 %
- 52 Week High 37.77
- 52 Week Low 8.61
About
Tactile Systems Technology, Inc., a medical technology company, is dedicated to the development and supply of medical devices for chronic diseases in the United States. The company is headquartered in Minneapolis, Minnesota.
Analyst Target Price
$38.00
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-18 | 2025-11-10 | 2025-08-04 | 2025-05-05 | 2025-02-18 | 2024-11-04 | 2024-08-05 | 2024-05-06 | 2024-02-20 | 2023-11-06 | 2023-08-07 | 2023-05-08 |
| Reported EPS | 0.46 | 0.36 | 0.14 | -0.1254 | 0.397 | 0.21 | 0.18 | -0.08 | 0.35 | 0.94 | 0.049 | -0.09 |
| Estimated EPS | 0.445 | 0.165 | 0.17 | -0.065 | 0.28 | 0.18 | 0.12 | -0.11 | 0.19 | 0.04 | -0.05 | -0.24 |
| Surprise | 0.015 | 0.195 | -0.03 | -0.0604 | 0.117 | 0.03 | 0.06 | 0.03 | 0.16 | 0.9 | 0.099 | 0.15 |
| Surprise Percentage | 3.3708% | 118.1818% | -17.6471% | -92.9231% | 41.7857% | 16.6667% | 50% | 27.2727% | 84.2105% | 2250% | 198% | 62.5% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-04 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.07 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: TCMD
2026-04-17 12:09:21
This article examines Tactile Systems Technology Inc. (US87874P1012), focusing on its home-based medical devices for lymphedema and chronic venous insufficiency. It analyzes the company's recurring revenue business model driven by consumables, its significant market opportunity in the underserved U.S. lymphedema market, and its potential for global expansion. The report also covers analyst views, key risks like Medicare reimbursement dependency, and future catalysts such as product pipeline updates and international pilot results.
2026-04-14 14:39:35
Tactile Systems Tech focuses on at-home lymphedema and chronic venous insufficiency therapies, positioning it well within the growing chronic disease market. The company's business model relies on pneumatic compression devices like the Flexitouch system, providing recurring revenue through supplies and leveraging Medicare reimbursement for home-based care. Investors should monitor evolving healthcare policies and competitive pressures, but the company's niche focus and clinical evidence provide a strong market position.
2026-04-13 06:09:28
Tactile Systems Technology (NASDAQ:TCMD) has received a consensus rating of "Moderate Buy" from seven brokerages, with an average 12-month price target of $37.40. The company recently surpassed earnings and revenue expectations, reporting $0.46 EPS against an expected $0.44, and $103.6 million in revenue compared to an estimated $93.8 million. Despite net insider selling, institutional investors maintain a significant ownership stake of approximately 83.43% in the medical device company.
2026-04-12 21:09:29
This article analyzes Tactile Systems Technology Inc. (TCMD) using AI models, highlighting weak near and mid-term sentiment despite a long-term positive outlook. It provides specific trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with entry, target, and stop-loss levels, and details multi-timeframe signal analysis for support and resistance levels. The analysis aims to guide traders based on market movements rather than prevailing narratives.
2026-04-09 20:40:15
This article compiles various press releases related to Tactile Systems Technology, Inc. (TCMD), including news about its stock performance, analyst ratings for medical device companies, executive appointments at LifeLens Technologies, and conference announcements by Sidoti & Company. It also features several reports from Kahn Swick & Foti, LLC, detailing ongoing investigations into the officers and directors of Tactile Systems Technology. The listed press releases range from 2021 to 2024, providing a historical overview of company and industry news relevant to TCMD.
2026-04-09 17:40:30
Tactile Systems Technology (TCMD) has maintained its fair value estimate at US$38.00 after its Q4 results and 2026 guidance, reflecting a consistent view of its upside potential despite varying analyst opinions. Bullish analysts from Lake Street, BTIG, and Piper Sandler raised their targets due to strong Q4 performance, productivity improvements, and increased FY2026 revenue guidance. Conversely, B. Riley maintained a "Neutral" stance, suggesting the current share price already incorporates these positives, limiting further upside for new buyers.
